Electrochemical Biosensor Based on Lectin-functionalized Nitrogen, Sulfur-doped Graphene Quantum Dot Decorated Gold Nanoparticles for Breast Cancer Diagnosis: From Academic Research to Clinical Translation
Launched by CHANG GUNG MEMORIAL HOSPITAL · Jun 15, 2025
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new tool designed to help detect breast cancer more quickly and accurately. The tool is a special sensor made from tiny materials that work together to find cancer cells in the body by measuring changes in electrical signals. This sensor is very sensitive and can detect even a small number of breast cancer cells, which could make early diagnosis easier and improve treatment outcomes.
The trial is open to adults aged 18 to 90. People who have been diagnosed with breast cancer and are planning to receive treatment at Chang Gung Hospital may be eligible, as well as healthy individuals without cancer for at least five years. Participants will be carefully screened to ensure they are suitable for the study. If you join, you can expect to help researchers understand how well this new sensor works in a real clinical setting, which may lead to better breast cancer detection tools in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 18-90
- • health participants: without cancer over 5 years
- • cancer participants: diagnosis of breast cancer
- • cancer participants: agree to receive treatment in Chang Gung hospital
- Exclusion Criteria:
- • mental disease
- • Physician's assessment not suitable
About Chang Gung Memorial Hospital
Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
CHIA-HSUN Hsieh, M.D PhD
Principal Investigator
Chang Gung Memorial Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported